Complement C1 inhibitor protein

2012 ◽  
Vol &NA; (1432) ◽  
pp. 18
Author(s):  
&NA;
Keyword(s):  
Inhibitor Protein ◽  
C1 Inhibitor

Complement C1 inhibitor protein

2012 ◽  
Vol &NA; (1389) ◽  
pp. 19
Author(s):  
&NA;
Keyword(s):  
Inhibitor Protein ◽  
C1 Inhibitor

scholarly journals Acquired Form of Angioedema of the Head and Neck Related to a Deficiency in C1-Inhibitor: A Case Report with a Review of the Literature

2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Bassel Hallak ◽  
Propser Konu ◽  
Florian Lang ◽  
Christian Simon ◽  
Philippe Monnier
Keyword(s):  
Case Report ◽  
Mortality Rate ◽  
Enzyme Inhibitor ◽  
Laryngeal Edema ◽  
Simultaneous Occurrence ◽  
Inhibitor Protein ◽  
C1 Inhibitor ◽  
Review Of The Literature ◽  
First Case ◽  
Causative Factors

Angioedema related to a deficiency in the C1-inhibitor protein is characterized by its lack of response to therapies including antihistamine, steroids, and epinephrine. In the case of laryngeal edema, mortality rate is approximately 30 percent. The first case of the acquired form of angioedema related to a deficiency in C1-inhibitor was published in 1972. In our paper, we present a case of an acquired form of angioedema of the oropharyngeal region secondary to the simultaneous occurrence of two causative factors: neutralization of C1-inhibitor by an autoantibody and the use of an angiotensin convertin enzyme inhibitor.

Classical pathway activity, C3C, C4 and C1-inhibitor protein reference intervals using Optilite® reagents in EDTA plasma

2019 ◽  
Vol 493 ◽  
pp. S693
Author(s):  
B. Lopez ◽  
N. Bertier ◽  
E. Ledoult ◽  
R. Joudinaud ◽  
M. Maanaoui ◽  
...  
Keyword(s):  
Reference Intervals ◽  
Classical Pathway ◽  
Inhibitor Protein ◽  
C1 Inhibitor ◽  
Pathway Activity ◽  
Edta Plasma
Sign in / Sign up

Export Citation Format

Share Document